Colorectal Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colorectal Cancer, including details on symptoms, genetics, screening, treatment, information.

Volume 4 (2007), Issue 1 (January)

1. A prospective pathologic analysis using whole-mount sections of rectal cancer following preoperative combined modality therapy: implications for sphincter preservation.
   Ann Surg, 245(1): 88-93. [Abstract] [Full-text]
2. Potential prognostic benefit of lateral pelvic node dissection for rectal cancer located below the peritoneal reflection.
   Ann Surg, 245(1): 80-7. [Abstract] [Full-text]
3. Reoperation as a quality indicator in colorectal surgery: a population-based analysis.
   Ann Surg, 245(1): 73-9. [Abstract] [Full-text]
4. Impact of laparoscopic resection for colorectal cancer on operative outcomes and survival.
   Ann Surg, 245(1): 1-7. [Abstract] [Full-text]
5. HLA-A, -B, -C expression in colon carcinoma mimics that of the normal colonic mucosa and is prognostically relevant.
   Am J Surg Pathol, 31(1): 76-84. [Abstract] [Full-text]
6. Balance between endoscopic and genetic information in the choice of ileorectal anastomosis for familial adenomatous polyposis.
   J Surg Oncol, 95(1): 28-33. [Abstract] [Full-text]
7. Long term administration of granulocyte-macrophage colony stimulating factor decreases development of 1-2 dimethylhydrazine-induced colon cancer in rats.
   J Surg Oncol, 95(1): 12-21. [Abstract] [Full-text]
8. Deoxycholic acid promotes the growth of colonic aberrant crypt foci.
   Mol Carcinog, 46(1): 60-70. [Abstract] [Full-text]
9. Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect peri-operative outcomes.
   J Surg Oncol, 95(1): 22-7. [Abstract] [Full-text]
10. Intestinal microbiota: a potential diet-responsive prevention target in ApcMin mice.
    Mol Carcinog, 46(1): 42-8. [Abstract] [Full-text]
11. Oncogenic KRAS provides a uniquely powerful and variable oncogenic contribution among RAS family members in the colonic epithelium.
    J Cell Physiol, 210(3): 740-9. [Abstract] [Full-text]
12. Nuclear IKK activity leads to dysregulated notch-dependent gene expression in colorectal cancer.
    Proc Natl Acad Sci U S A, 104(1): 276-81. [Abstract] [Full-text]
13. Statins and the risk of lung, breast, and colorectal cancer in the elderly.
    Circulation, 115(1): 27-33. [Abstract] [Full-text]
14. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice.
    Nature, 445(7123): 106-10. [Abstract] [Full-text]
15. Identification and expansion of human colon-cancer-initiating cells.
    Nature, 445(7123): 111-5. [Abstract] [Full-text]
16. Statin use and risk of colorectal cancer.
    J Natl Cancer Inst, 99(1): 32-40. [Abstract] [Full-text]
17. Octreotide improved the quality of life in a child with malignant bowel obstruction caused by peritoneal dissemination of colon cancer.
    J Pediatr Surg, 42(1): 259-60. [Abstract] [Full-text]
18. Tumour selection advantage of non-dominant negative P53 mutations in homozygotic MDM2-SNP309 colorectal cancer cells.
    J Med Genet, 44(1): 75-80. [Abstract] [Full-text]
19. Establishment of human colon cancer cell lines from fresh tumors versus xenografts: comparison of success rate and cell line features.
    Cancer Res, 67(1): 398-407. [Abstract] [Full-text]
20. Inactivated Sendai virus particles eradicate tumors by inducing immune responses through blocking regulatory T cells.
    Cancer Res, 67(1): 227-36. [Abstract] [Full-text]
21. TRAIL induces receptor-interacting protein 1-dependent and caspase-dependent necrosis-like cell death under acidic extracellular conditions.
    Cancer Res, 67(1): 218-26. [Abstract] [Full-text]
22. Gene expression profiling reveals a massive, aneuploidy-dependent transcriptional deregulation and distinct differences between lymph node-negative and lymph node-positive colon carcinomas.
    Cancer Res, 67(1): 41-56. [Abstract] [Full-text]
23. Extramural cancer deposits without nodal structure in colorectal cancer: optimal categorization for prognostic staging.
    Am J Clin Pathol, 127(2): 287-94. [Abstract] [Full-text]
24. An approach to interpreting immunohistochemical stains of adenocarcinoma in small needle core biopsy specimens: the impact of limited specimen size.
    Am J Clin Pathol, 127(2): 273-81. [Abstract] [Full-text]
25. Serrated carcinomas form a subclass of colorectal cancer with distinct molecular basis.
    Oncogene, 26(2): 312-20. [Abstract] [Full-text]
26. Operative time is a poor surrogate for the learning curve in laparoscopic colorectal surgery.
    Surg Endosc, 21(2): 238-43. [Abstract] [Full-text]
27. Comparison of colonic stenting and open surgery for malignant large bowel obstruction.
    Surg Endosc, 21(2): 225-33. [Abstract] [Full-text]
28. Laparoscopic resection with intraoperative radiotherapy: a new step in the multimodal treatment of advanced colorectal cancer.
    Surg Endosc, 21(2): 330-2. [Abstract] [Full-text]
29. Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array.
    BMC Genomics, 7: 325. [Abstract] [Full-text]
30. aCGH local copy number aberrations associated with overall copy number genomic instability in colorectal cancer: coordinate involvement of the regions including BCR and ABL.
    Mutat Res, 615(1): 1-11. [Abstract] [Full-text]
31. Surgeon and hospital characteristics as predictors of major adverse outcomes following colon cancer surgery: understanding the volume-outcome relationship.
    Arch Surg, 142(1): 23-31; discussion 32. [Abstract] [Full-text]
32. Trends in colonoscopy for colorectal cancer screening.
    Med Care, 45(2): 160-7. [Abstract] [Full-text]
33. Prolonged effect of calcium supplementation on risk of colorectal adenomas in a randomized trial.
    J Natl Cancer Inst, 99(2): 129-36. [Abstract] [Full-text]
34. Synchronous adenocarcinomas of intestinal type of the inner nose and the colon.
    Hum Pathol, 38(2): 373-7. [Abstract] [Full-text]
35. Annexin II binds progastrin and gastrin-like peptides, and mediates growth factor effects of autocrine and exogenous gastrins on colon cancer and intestinal epithelial cells.
    Oncogene, 26(3): 425-40. [Abstract] [Full-text]
36. Correlation of K-ras codon 12 mutations in human feces and ages of patients with colorectal cancer (CRC).
    Transl Res, 149(2): 96-102. [Abstract] [Full-text]
37. Association between pathologic response in metastatic lymph nodes after preoperative chemoradiotherapy and risk of distant metastases in rectal cancer: An analysis of outcomes in a randomized trial.
    Int J Radiat Oncol Biol Phys, 67(2): 369-77. [Abstract] [Full-text]
38. Comparison of 5-fluorouracil/leucovorin and capecitabine in preoperative chemoradiotherapy for locally advanced rectal cancer.
    Int J Radiat Oncol Biol Phys, 67(2): 378-84. [Abstract] [Full-text]
39. MUC1-specific immune therapy generates a strong anti-tumor response in a MUC1-tolerant colon cancer model.
    Vaccine, 25(9): 1607-18. [Abstract] [Full-text]
40. Mutation analysis of aryl hydrocarbon receptor interacting protein (AIP) gene in colorectal, breast, and prostate cancers.
    Br J Cancer, 96(2): 352-6. [Abstract] [Full-text]
41. Mechanism of trifluorothymidine potentiation of oxaliplatin-induced cytotoxicity to colorectal cancer cells.
    Br J Cancer, 96(2): 231-40. [Abstract] [Full-text]
42. The relationship between patient physiology and cancer-specific survival following curative resection of colorectal cancer.
    Br J Cancer, 96(2): 213-7. [Abstract] [Full-text]
43. Cost-effectiveness analysis of cetuximab/irinotecan vs active/best supportive care for the treatment of metastatic colorectal cancer patients who have failed previous chemotherapy treatment.
    Br J Cancer, 96(2): 206-12. [Abstract] [Full-text]
44. Rectal carcinoma: MRI with histologic correlation before and after chemoradiation therapy.
    AJR Am J Roentgenol, 188(2): 442-51. [Abstract] [Full-text]
45. Diagnostic accuracy of rim and segmental MRI enhancement of colorectal hepatic metastasis after administration of mangafodipir trisodium.
    AJR Am J Roentgenol, 188(2): W154-61. [Abstract] [Full-text]
46. Association of FOBT-assessed faecal Hb content with colonic lesions detected in the Florence screening programme.
    Br J Cancer, 96(2): 218-21. [Abstract] [Full-text]
47. C-reactive protein as a predictor of prognosis following curative resection for colorectal liver metastases.
    Br J Cancer, 96(2): 222-5. [Abstract] [Full-text]
48. Olympus Lucera high-resolution vascular ectasia mapping in combination with the type V crypt pattern for the invasive depth estimation and nodal disease estimation in Paris type II colorectal cancers: a comparative prospective analysis to 20 MHz ultrasound.
    J Clin Gastroenterol, 41(2): 178-84. [Abstract] [Full-text]
49. Age and time as factors in the left-to-right shift of the subsite of colorectal adenocarcinoma: a study of 213,383 cases from the California Cancer Registry.
    J Clin Gastroenterol, 41(2): 173-7. [Abstract] [Full-text]
50. Combination of SELDI-TOF-MS and data mining provides early-stage response prediction for rectal tumors undergoing multimodal neoadjuvant therapy.
    Ann Surg, 245(2): 259-66. [Abstract] [Full-text]
51. Calcium, dietary, and lifestyle factors in the prevention of colorectal adenomas.
    Cancer, 109(3): 510-7. [Abstract] [Full-text]
52. Racial differences in tumor stage and survival for colorectal cancer in an insured population.
    Cancer, 109(3): 612-20. [Abstract] [Full-text]
53. Disease-associated casein kinase I delta mutation may promote adenomatous polyps formation via a Wnt/beta-catenin independent mechanism.
    Int J Cancer, 120(5): 1005-12. [Abstract] [Full-text]
54. MTHFR C677T and colorectal cancer risk: A meta-analysis of 25 populations.
    Int J Cancer, 120(5): 1027-35. [Abstract] [Full-text]
55. Colorectal carcinoma in childhood: a retrospective multicenter study.
    J Pediatr Gastroenterol Nutr, 44(2): 209-11. [Abstract] [Full-text]
56. Immunohistochemical staining for p63 is useful in the diagnosis of anal squamous cell carcinomas.
    Am J Surg Pathol, 31(2): 285-90. [Abstract] [Full-text]
57. Clinicopathologic and immunohistochemical study of small apparently "de novo" colorectal adenocarcinomas.
    Am J Surg Pathol, 31(2): 207-15. [Abstract] [Full-text]
58. Differentiation between diverticulitis and colorectal cancer: quantitative CT perfusion measurements versus morphologic criteria--initial experience.
    Radiology, 242(2): 456-62. [Abstract] [Full-text]
59. Medulloblastoma, acute myelocytic leukemia and colonic carcinomas in a child with biallelic MSH6 mutations.
    Nat Clin Pract Oncol, 4(2): 130-4. [Abstract] [Full-text]
60. Quality of life in operable colon cancer patients receiving oral compared with intravenous chemotherapy: results from National Surgical Adjuvant Breast and Bowel Project Trial C-06.
    J Clin Oncol, 25(4): 424-30. [Abstract] [Full-text]
61. STAT3 mRNA and protein expression in colorectal cancer: effects on STAT3-inducible targets linked to cell survival and proliferation.
    J Clin Pathol, 60(2): 173-9. [Abstract] [Full-text]

© 2004-2008 Colorectal Cancer Research Today. All Rights Reserved.